The burning question: Why is smoking a risk factor for pancreatic cancer?

Pancreatology

Volumn 12, Issue 4, 2012, Pages 344-349

  Pandol, Stephen J ^a   Apte, Minoti V ^b   Wilson, Jeremy S ^b   Gukovskaya, Anna S ^a   Edderkaoui, Mouad ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Fibrosis; Inflammation; Pancreatic cancer; Smoking

Indexed keywords

CARCINOGEN;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER REGRESSION; CANCER RISK; CELL DEATH; CELL PROLIFERATION; CIGARETTE SMOKING; CYSTIC FIBROSIS; HEREDITY; HUMAN; INFLAMMATORY CELL; INHIBITION KINETICS; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SMOKING;

EID: 84866514182     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2012.06.002     Document Type: Review

References (75)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96. (Pubitemid 351521864)
2. Wilson LS, Lightwood JM. Pancreatic cancer: total costs and utilization of health services. J Surg Oncol 1999;71:171-81. (Pubitemid 29340781)
3. Philip PA. Targeted therapies for pancreatic cancer. Gastrointest Cancer Res 2008;2(4 Suppl):S16-9.
4. Bayraktar S, Bayraktar UD, Rocha-Lima CM. Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer. World J Gastroenterol 2010;16(6):673-82.
5. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, et al. Pancreatitis and the risk of pancreatic cancer. International pancreatitis study group. N Engl J Med 1993;328:1433-7. (Pubitemid 23143844)
6. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 2010;24(3):349-58.
7. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008;134:95-101. (Pubitemid 350309328)
8. Gupta S, Vittinghoff E, Bertenthal D, Corley D, Shen H, Walter LC, et al. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol 2006;4:1366-72. (Pubitemid 44781089)
9. Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis 2010;28(4-5):645-56.
10. Lowenfels AB, Maisonneuve P. Environmental factors and risk of pancreatic cancer. Pancreatology 2003;3:1-8.
11. Raimondi S, Maisonneuve P, Löhr J-M, Lowenfels AB. Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors. Canc Epidem Biomark Prev 2007;16:1894. 1055-9965.
12. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144(5):646-74.
13. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
14. Fidler IJ. The organ microenvironment and cancer metastasis. Differentiation 2002;70:498-505. (Pubitemid 36194315)
15. Liotta LA, Kohn EC. The microenvironment of the tumor-host interface. Nature 2001;411:375-9.
16. Carrière C, Young AL, Gunn JR, Longnecker DS, Korc M. Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the Nestin cell lineage. PLoS One 2011;6(11):e27725.
17. Fukuda A, Wang SC, Morris 4th JP, Folias AE, Liou A, Kim GE, et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011;19(4):441-55.
18. Watanabe I, Hasebe T, Sasaki S, Konishi M, Inoue K, Nakagohri T, et al. Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin expression correlate with outcome. Pancreas 2003;26:326-33. (Pubitemid 36529956)
19. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998;43(1):128-33. (Pubitemid 28335501)
20. Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DH, et al. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 1999;155(4):1087-95. (Pubitemid 29488916)
21. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008;68(3):918-26. (Pubitemid 351206771)
22. Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, Parker NR, et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res 2008; 68(7):2085-93. (Pubitemid 351521780)
23. Xu Z, Vonlaufen A, Phillips PA, Fiala-Beer E, Zhang X, Yang L, et al. Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol 2010; 177(5):2585-96.
24. Erkan M, Kleeff J, Gorbachevski A, Reiser C, Mitkus T, Esposito I, et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 2007;132(4):1447-64. (Pubitemid 46627568)
25. Mantoni TS, Lunardi S, Al-Assar O, Masamune A, Brunner TB. Pancreatic stellate cells radioprotect pancreatic cancer cells through beta1-integrin signaling. Cancer Res 2011;71(10):3453-8.
26. Vaquero EC, Edderkaoui M, Nam KJ, Gukovsky I, Pandol SJ, Gukovskaya AS. Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways. Gastroenterology 2003; 125(4):1188-202. (Pubitemid 37193464)
27. Edderkaoui M, Hong P, Vaquero EC, Lee JK, Fischer L, Friess H, et al. Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. Am J Physiol Gastrointest Liver Physiol 2005;289(6):G1137.
28. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 2004;279(33):34643-54. (Pubitemid 39318094)
29. Lee JK, Edderkaoui M, Truong P, Ohno I, Jang KT, Berti A, et al. NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases. Gastroenterology 2007;133(5):1637-48. (Pubitemid 350029743)
30. Edderkaoui M, Odinokova I, Ohno I, Gukovsky I, Go VL, Pandol SJ, et al. Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol 2008;14(23):3672-80.
31. Hu R, Wang YL, Edderkaoui M, Lugea A, Apte MV, Pandol SJ. Ethanol augments PDGF-induced NADPH oxidase activity and proliferation in rat pancreatic stellate cells. Pancreatology 2007;7:332-40. (Pubitemid 47482094)
32. Pandol S, Edderkaoui M, Gukovsky I, Lugea A, Gukovskaya A. Desmoplasia of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 2009;7(Suppl. 11):S44-7.
33. Grippo PJ, Nowlin PS, Demeure MJ, Longnecker DS, Sandgren EP. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res 2003;63(9):2016-9. (Pubitemid 36538599)
34. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4(6):437-50. (Pubitemid 38050041)
35. Ji B, Tsou L, Wang H, Gaiser S, Chang DZ, Daniluk J, et al. Ras activity levels control the development of pancreatic diseases. Gastroenterology 2009; 137(3):1072-82.
36. Morris PD. Lifetime excess risk of death from lung cancer for a U.S. female never-smoker exposed to environmental tobacco smoke. Environ Res 1995; 68:3-9.
37. Heidrich J, Wellmann J, Heuschmann PU, Kraywinkel K, Keil U. Mortality and morbidity from coronary heart disease attributable to passive smoking. Eur Heart J 2007;28:2498-502. (Pubitemid 47614272)
38. Alberg AJ, Ford JG, Samet JM. American college of chest physicians: epidemiology of lungcancer. ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(Suppl. 3):29Se55S.
39. McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control 2003;10(4): 325-33. (Pubitemid 36919545)
40. Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, et al. Cancer survivorshipdgenetic susceptibility and second primary cancers: research strategies and recommendations. J Nat Cancer Inst 2006;98(1): 15-25. (Pubitemid 43057089)
41. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. Br Med J 2010;340:b5569.
42. Mack TM, Yu MC, Hanisch R, Henderson BE. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986; 76(1):49-60. (Pubitemid 16156103)
43. Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol 2009;170(4):403-13.
44. Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P,, et alEuropean Registry of Hereditary Pancreatitis and Pancreatic Cancer (EUROPAC). Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastro Hep 2004;2(3):252-61. (Pubitemid 38293313)
45. Weiss W, Benarde MA. The temporal relation between cigarette smoking and pancreatic cancer. Am J Public Health 1983;73(12):1403-4. (Pubitemid 14225228)
46. Whittemore AS, Paffenbarger Jr RS, Anderson K, Halpern J. Early precursors of pancreatic cancer in college men. J Chronic Dis 1983;36(3):251-6. (Pubitemid 13160594)
47. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008; 393(4):535-45.
48. U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
49. Hecht SS. Cigarette smoking, cancer risks, carcinogens and mechanisms. Langenbecks Arch Surg 2006;391:603-13. (Pubitemid 44657742)
50. Wen J, Fu JH, Zhang W, Guo M. Lung carcinoma signaling pathways activated by smoking. Chin J Cancer 2011;30(8):551-8.
51. Hoffmann D, Hoffmann I, El-Bayoumy K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol 2001; 14(7):767-90. (Pubitemid 32663874)
52. Henningfield JE, Fant RV, Radzius A, Frost S. Nicotine concentration, smoke pH and whole tobacco aqueous pH of some cigar brands and types popular in the United States. Nic Tobac Res 1999;1(2):163-8.
53. Le Houezec J. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Int J Tuberc Lung Dis 2003;7(9): 811-9. (Pubitemid 37158418)
54. Chowdhury P, Doi R, Chang LW, Rayford PL. Tissue distribution of [3H]-nicotine in rats. Biomed Environ Sci 1993;6(1):59-64.
55. Prokopczyk B, Hoffmann D, Bologna M, Cunningham AJ, Trushin N, Akerkar S, et al. Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 2002;15(5):677-85. (Pubitemid 34535123)
56. Nicolov IG, Chernozemsky IN. Tumors and hyperplastic lesions in Syrian hamsters following transplacental and neonatal treatment with cigarette smoke condensate. J Cancer Res Clin Oncol 1979;94(3):249-56. (Pubitemid 9229899)
57. Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and arecaderived N-nitrosamines. Cancer Res 1988;48(23):6912-7. (Pubitemid 19012226)
58. Bersch VP, Osvaldt AB, Edelweiss MI, Schumacher Rde C, Wendt LR, Abreu LP, et al. Effect of nicotine and cigarette smoke on an experimental model of intraepithelial lesions and pancreatic adenocarcinoma induced by 7,12-dimethylbenzanthracene in mice. Pancreas 2009;38(1):65-70.
59. Edderkaoui M, Park C, Lee I, Nitsche C, Gerloff A, Grippo PJ, et al. Novel model of pancreatic neoplastic lesions induced by smoking compound NNK. Pancreas 2011;40(8):1320 [Abstract].
60. Schuller HM, Tithof PK, Williams M, Plummer 3rd H. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via betaadrenergic receptor-mediated release of arachidonic acid. Cancer Res 1999; 59(18):4510-5. (Pubitemid 29428948)
61. Schuller HM, Cekanova M. NNK-induced hamster lung adenocarcinomas overexpress beta2-adrenergic and EGFR signaling pathways. Lung Cancer 2005; 49(1):35-45. (Pubitemid 40798091)
62. Porta M, Crous-Bou M, Wark PA, Vineis P, Real FX, Malats N, et al. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes. Mutat Res 2009;682(2-3):83-93.
63. Blackford A, Parmigiani G, Kensler TW, Wolfgang C, Jones S, Zhang X, et al. Genetic mutations associated with cigarette smoking in pancreatic cancer. Cancer Res 2009;69(8):3681-8.
64. Weddle DL, Tithoff P, Williams M, Schuller HM. Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis 2001;22(3):473-9. (Pubitemid 32203828)
65. Askari MD, Tsao MS, Schuller HM. The tobacco-specific carcinogen, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol 2005;131(10): 639-48. (Pubitemid 41502206)
66. Askari MD, Tsao MS, Cekanova M, Schuller HM. Ethanol and the tobaccospecific carcinogen, NNK, contribute to signaling in immortalized human pancreatic duct epithelial cells. Pancreas 2006;33:53-62. (Pubitemid 43995340)
67. Yoshikawa H, Hellström-Lindahl E, Grill V. Evidence for functional nicotinic receptors on pancreatic beta cells. Metabolism 2005;54:247-54. (Pubitemid 40174855)
68. Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res 2012;91(2):142-9.
69. Alexandre M, Pandol SJ, Gorelick FS, Thrower EC. The Emerging role of smoking in the development of pancreatitis. Pancreatology 2011;11(5): 469-74.
70. Chowdhury P, Doi R, Tangoku A, Rayford PL. Structural and functional changes of rat exocrine pancreas exposed to nicotine. Int J Pancreatol 1995;18(3): 257-64. (Pubitemid 26023508)
71. Dubick MA, Palmer R, Lau PP, Morrill PR, Geokas MC. Altered exocrine pancreatic function in rats treated with nicotine. Toxicol Appl Pharmacol 1988;96(1):132-9.
72. Lau PP, Dubick MA, Yu GS, Morrill PR, Geokas MC. Dynamic changes of pancreatic structure and function in rats treated chronically with nicotine. Toxicol Appl Pharmacol 1990;104(3):457-65. (Pubitemid 20262474)
73. Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, et al. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol 2006;101(1):148-59. (Pubitemid 43381723)
74. Soeda J, Morgan M, McKee C, Mouralidarane A, Lin C, Roskams T, et al. Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. Biochem Biophys Res Commun 2012;417(1):17-22.
75. Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004;57:630-6. (Pubitemid 38725766)